JPM vs OBK
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
Origin Bancorp presents a stark contrast between strong growth and poor fundamental health, highlighted by a weak Piotroski F-Score of 2/9. While the stock is attractively valued below its Graham Number ($48.67) and significantly below its intrinsic value ($76.11), the low health score suggests underlying operational or financial instability. Strong earnings growth (25.4% YoY) and a consistent track record of beating estimates provide a bullish catalyst, but these are offset by a bearish technical trend and low ROE. The overall outlook is neutral until the fundamental health metrics improve to match the growth trajectory.
Compare Another Pair
Related Comparisons
JPM vs OBK: Head-to-Head Comparison
This page compares JPMorgan Chase & Co. (JPM) and Origin Bancorp, Inc. (OBK) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.